Publication | Open Access
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
24
Citations
28
References
2022
Year
Cancer ImmunosurveillanceMedicineImmunologyImmune Checkpoint InhibitorCancer TreatmentImmunotherapyOncologyCell BiologyRecurrent/metastatic Nasopharyngeal Carcinoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1